Leucemie limfatica cronica post covid se poate administra ?

Oamenii de stiinta studiaza NAD/NADH ca trarament complementar in ocologie dar aceste studii sunt inca incerte.

"NAD Metabolism in Cancer Therapeutics

Keisuke Yaku1, Keisuke Okabe1,2, Keisuke Hikosaka1 and Takashi Nakagawa1,3*"

Sunt si studii care condraindica NAD in cancer.

NAD+ metabolism, stemness, the immune response,and cancer
Lola E. Navas1,2 and Amancio Carnero:

"However, the balance is very narrow and must be better defined for therapeutical approaches, since decreasing NAD may lead to a decrease in pluripotency, aging, neurodegeneration, and immune response, while an excessive increase may contribute to cancer. More efforts are necessary to establish the therapeutic window for cancer without contributing to other NAD-derived illness or toxicity."

"NAD+ Metabolism in Cancer and Cancer Therapies
Sara Ryding
Reviewed by Emily Henderson, B.Sc."

Deoarece nu sujnt date suficiente, la pacientul oncologic administrarea de NADH nu se recomanda.

In ceea ce priveste leucemia limfatica cronica, situatia este asemanatoare.

"Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-Cell
Chronic Lymphocytic Leukemia (CLL)
Savita Bhalla and Leo I. Gordon"

"Targeting the vulnerability to NAD + depletion in B-cell acute lymphoblastic leukemia
S Takao 1, W Chien 1 2, V Madan 1, D-C Lin 1 2, L-W Ding 1, Q-Y Sun 1, A Mayakonda 1, M Sudo 1, L Xu 1, Y Chen 1, Y-Y Jiang 1, S Gery 2, M Lill 2, E Park 3, W Senapedis 4, E Baloglu 4, M Müschen 5, H P Koeffler 1 2 6"


Cu drag
Farm Emanuela Bucur